SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 35661.
  • 2
    Liu H, Pope RM. Apoptosis in rheumatoid arthritis: friend or foe. Rheum Dis Clin North Am 2004; 30: 60325.
  • 3
    Szekanecz Z, Gaspar L, Koch AE. Angiogenesis in rheumatoid arthritis. Front Biosci 2005; 10: 173953.
  • 4
    Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev 2005; 204: 5573.
  • 5
    Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32: 9037.
  • 6
    Tosato G. Generation of Epstein-Barr virus (EBV)-immortalized B cell lines. In: ColiganJE, KruisbeekAM, MarguliesDH, ShevachEM, StroberW, editors. Current protocols in immunology. New York: John Wiley & Sons; 1998. p. 7.22.17.22.3.
  • 7
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 8
    Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 50514.
  • 9
    Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 8226.
  • 10
    Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98: 511621.
  • 11
    Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 148638.
  • 12
    Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al, and the Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat Genet 2000; 25: 259.
  • 13
    Maglott DR, Katz KS, Sicotte H, Pruitt KD. NCBI's LocusLink and RefSeq. Nucleic Acids Res 2000; 28: 1268.
  • 14
    Ruth JH, Volin MV, Haines GK 3rd, Woodruff DC, Katschke KJ Jr, Woods JM, et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 2001; 44: 156881.
  • 15
    Fujiwara H, Higuchi T, Yamada S, Hirano T, Sato Y, Nishioka Y, et al. Human extravillous trophoblasts express laeverin, a novel protein that belongs to membrane-bound gluzincin metallopeptidases. Biochem Biophys Res Commun 2004; 313: 9628.
  • 16
    Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003; 48: 21737.
  • 17
    Van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003; 48: 213245.
  • 18
    Zhang HG, Hyde K, Page GP, Brand JP, Zhou J, Yu S, et al. Novel tumor necrosis factor α–regulated genes in rheumatoid arthritis. Arthritis Rheum 2004; 50: 42031.
  • 19
    Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG, et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high inflammation synovitis. Arthritis Rheum 2005 52: 430441.
  • 20
    Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, Wagner U, et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004; 172: 125665.
  • 21
    Munshi NC, Hideshima T, Carrasco D, Shammas M, Auclair D, Davies F, et al. Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood 2004; 103: 1799806.
  • 22
    Teuffel O, Betts DR, Dettling M, Schaub R, Schafer BW, Higgli FK. Prenatal origin of separate evolution of leukemia in identical twins. Leukemia 2004; 18: 16249.
  • 23
    Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, Kusumi I, et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 2003; 35: 1715.
  • 24
    Tan Q, Christensen K, Christiansen L, Fredriksen H, Bathum L, Dahlgaard J, et al. Genetic dissection of gene expression observed in whole blood samples of elderly Danish twins. Hum Genet 2005; 117: 26774.
  • 25
    Wagner U, Kaltenhauser S, Pierer M, Wilke B, Arnold S, Hantzscel H. B lymphocytopenia in rheumatoid arthritis is associated with the DRB1 shared epitope and increased acute phase response. Arthritis Res 2002; 4: R1.
  • 26
    Symmons DP, Farr M, Salmon M, Bacon PA. Lymphopenia in rheumatoid arthritis. J R Soc Med 1989; 82: 4623.
  • 27
    Banks RE, Aiton JF, Cram G, Naylor GJ. Incorporation of inositol into the phophoinositides of lymphoblastoid cell lines from bipolar manic-depressive patients. J Affect Disord 1990; 19: 18.
  • 28
    Yoon IS, Li PP, Siu KP, Kennedy JL, Cooke RG, Parikh SV, et al. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Mol Psychiatry 2001; 6: 67883.
  • 29
    Pi X, Tan SY, Hayes M, Xiao L, Shayman JA, Ling S, et al. Sphingosine kinase 1–mediated inhibition of Fas death signaling in rheumatoid arthritis B lymphoblastoid cells. Arthritis Rheum 2006; 54: 75464.
  • 30
    Negrier C, Vinciguerra C, Attali O, Grenier C, Larcher ME, Dechavanne M. Illegitimate transcription: its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann throbasthenia. Br J Haematol 1998; 100: 339.
  • 31
    Tao Q, Roberston KD. Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 2003; 109: 5363.
  • 32
    Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005; 102: 106049.
  • 33
    Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33: 166573.
  • 34
    Sawada S, Takei M. Epstein-Barr virus etiology in rheumatoid synovitis. Autoimmun Rev 2005; 4: 10610.
  • 35
    Puga Yung GL, Le TD, Roord S, Prakken B, Albani S. Heat shock proteins for immunotherapy of rheumatoid arthritis. Inflamm Res 2003; 52: 44351.
  • 36
    Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, et al. Growth-related gene product α: a chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995; 155: 36606.
  • 37
    Konig A, Krenn V, Toksoy A, Gerhard N, Gillitzer R. Mig, GROα and RANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Virchows Arch 2000; 436: 44958.
  • 38
    Shadidi KR, Aarvak T, Henriksen JE, Natvig JB, Thompson KM. The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue. Scand J Immunol 2003; 57: 1928.
  • 39
    Myers SL, Christine TA. Measurement of β-thromboglobulin connective tissue activating peptide-III platelet antigen concentrations in pathologic synovial fluids. J Rheumatol 1982; 9: 612.
  • 40
    Matsui T, Akahoshi T, Namai R, Hashimoto A, Kurihara Y, Rana M, et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis. Clin Exp Immunol 2001; 125: 15561.
  • 41
    Ruth JH, Shahrara S, Park CC, Morel JC, Kumar P, Qin S, et al. Role of macrophage inflammatory protein-3α and its ligand CCR6 in rheumatoid arthritis. Lab Invest 2003; 83: 57988.
  • 42
    Taki K, Ogushi F, Kawano T, Tada H, Hariguchi N, Sone S. CD13/aminopeptidase N: a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis. Am J Respir Crit Care Med 2000; 161: 17.
  • 43
    Hansen AS, Noren O, Sjostrom H, Werdelin O. A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be coexpressed with major histocompatibility complex class II molecules. Eur J Immunol 1993; 23: 235864.
  • 44
    Shimizu T, Tani K, Hase K, Ogawa H, Huang L, Shinomiya F, et al. CD13/aminopeptidase N–induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 23308.
  • 45
    Sandeep TC, Walker BR. Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases. Trends Endocrinol Metab 2001; 12: 44653.
  • 46
    Lamberts SW, Huizenga AT, de Lange P, de Jong FH, Koper JW. Clinical aspects of glucocorticoid sensitivity. Steroids 1996; 61: 15760.
  • 47
    Horigome H, Hirano T, Oka K. Therapeutic effect of glycyrrhetinic acid in MRL lpr/lpr mice: implications of alteration of corticosteroid metabolism. Life Sci 2001; 69: 242938.
  • 48
    Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M, Stewart PM. Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone. Bone 2000; 27: 37581.
  • 49
    Perkowski S, Sun J, Singhal S, Santiago J, Leikauf GD, Albelda SM. Gene expression profiling of the early pulmonary response to hyperoxia in mice. Am J Respir Cell Mol Biol 2003; 28: 68296.
  • 50
    Lantz M, Vondrichova T, Parikh H, Frenander C, Ridderstrale M, Asman P, et al. Overexpression of immediate early genes in active Graves' ophthalmopathy. J Clin Endocrinol Metab 2005; 90: 478491.